Royal Sense Ltd Stock Price Today (NSE: ROYAL)

Royal Sense Ltd

116.000.60 (0.51%)
Market Closed

Fundamental Score

...

Royal Sense Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Royal Sense Ltd share price today is 116.00, down 0.51% on NSE/BSE as of 17 June 2026. Royal Sense Ltd (ROYAL) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of 109.14 (Cr). The 52-week high for ROYAL share price is 309.75 and the 52-week low is 120.00. At a P/E ratio of 13.61x, ROYAL is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 27.55% and a debt-to-equity ratio of 0.19.

Royal Sense Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
156.60
Low
116.00
Volume
4.5K
Change
-6.47%

Royal Sense Ltd share price chart: -6.47% return over the past month. 52-week high ₹309.75, 52-week low ₹120.00.

Royal Sense Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
126.30126.30120.00120.608.00K (Cr)
125.50127.10125.00127.102.50K (Cr)
130.00130.00127.00127.103.00K (Cr)
136.25136.25133.00133.003.00K (Cr)
126.20132.00125.00130.3522.50K (Cr)
141.70141.70141.70141.70500.00 (Cr)
132.00132.00132.00132.001.00K (Cr)
133.00134.00133.00134.001.00K (Cr)
135.00135.00125.00130.507.00K (Cr)
140.00140.00140.00140.001.00K (Cr)

Royal Sense Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
125.50127.10120.00120.60-3.90%
155.00156.15125.00127.10-18.00%
128.00198.00128.00156.60+22.34%
169.00169.00122.00125.00-26.04%
179.85210.00153.00172.00-4.36%
190.00195.00154.00172.20-9.37%
202.50255.90180.00191.45-5.46%
244.00253.00200.00205.40-15.82%
260.00260.00213.30231.00-11.15%
282.00282.00241.20254.50-9.75%
207.00309.75205.00284.25+37.32%
240.00240.00195.70207.00-13.75%

AI Research Briefing

Powered by Gemini · 2026-04-09

Micro-cap medical supplier with recent price momentum, but faces cash flow and liquidity risks.

Research Confidence
6.0/10Moderate
MICRO-CAP DARK HORSERecent price rise, but 1M, 3M, and 6M performance still negative [cite: brief, 10].Cheap based on P/E vs. industry, but concerning given poor historical growth [cite: brief, 14].

WHAT'S HAPPENING NOW (last 2-4 weeks)

Royal Sense Ltd's stock price has seen significant movement recently, prompting a clarification request from the Exchange on April 7, 2026. The company is yet to respond. The stock is currently

CORE STORY (THE REAL GAME)

Royal Sense is attempting to position itself as a comprehensive supplier to the medical industry, but faces challenges in translating revenue growth into consistent cash flow.

Why Now
  • Significant price movement triggers exchange inquiry
  • Recent YoY profit and sales growth [cite: brief]
  • Low P/E relative to industry [cite: brief]
Potential Catalysts
  • Positive response to exchange inquiry
  • Consistent conversion of profit to cash
  • New order wins
Key Risks
  • Micro/SME cap = liquidity risk
  • Poor historical profit and revenue growth
  • Weak cash conversion
Institutional Activity

Promoter holding steady at 62.24%. No FII/DII activity [cite: brief].

Macro Context

India's medical devices sector is experiencing growth, driven by expanding healthcare infrastructure and increasing insurance penetration.

Cash Flow Quality

No. Operating cash flow is significantly lower than net profit.

3–6 Month Outlook

If Royal Sense can sustain its recent growth and improve cash conversion, it could re-rate. However, failure to do so will likely lead to a correction.

Primary Thesis Risk

Illiquidity and poor cash conversion could lead to a value trap.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Excellent

Return on Equity (ROE)

27.55%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

35.18%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Royal Sense Ltd Valuation Check

Excellent

Price to Earnings (P/E)

13.61x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

47.87x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

62.24%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

70.59%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

97.46%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.19x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

20.98x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Royal Sense Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ROYAL across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Return on Equity (27.55%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (35.18%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 13.61 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (70.59%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (97.46%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.19)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (20.98x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (62.24%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

1 factors identified

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Royal Sense Ltd vs Medical Equipment & Supplies Peers

Peer Comparison - Medical Equipment & Supplies

Compare Royal Sense Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
52.1/100
116
₹109.14
13.6
Average
27.55%
Excellent
35.18%
Excellent
0.2
Excellent
0.00%
60.7/100
1330
₹19506.20
53.9
Average
15.77%
Good
20.08%
Excellent
0.1
Excellent
28.38%
Excellent
19.44%
Excellent
0.18%
31.7/100
37
₹3162.93
157.5
Average
0.70%
Poor
1.08%
Poor
0.1
Excellent
0.01%
68.7/100
243
₹1488.44
57.8
Average
21.88%
Excellent
19.20%
Good
0.0
Excellent
57.51%
Excellent
9.81%
Good
0.00%
42.1/100
497
₹1363.11
50.1
Average
30.08%
Excellent
31.14%
Excellent
0.6
Good
0.00%
13.8/100
215
₹1224.98
59.6
Average
4.75%
Poor
6.91%
Poor
0.6
Good
0.00%
60.3/100
173
₹633.93
25.8
Average
36.78%
Excellent
31.12%
Excellent
0.5
Good
90.06%
Excellent
61.82%
Excellent
0.00%
68.5/100
408
₹521.17
26.2
Average
18.74%
Good
25.25%
Excellent
0.0
Excellent
29.49%
Excellent
22.80%
Excellent
0.23%
61.2/100
413
₹354.57
34.2
Average
13.58%
Average
16.35%
Good
0.4
Excellent
74.11%
Excellent
13.69%
Good
0.00%
47.7/100
187
₹294.37
32.7
Average
13.56%
Average
18.45%
Good
0.0
Excellent
0.00%
Nureca Ltd...
NURECA543264
36/100
272
₹292.61
71.2
Average
-1.12%
Poor
-0.90%
Poor
0.0
Excellent
1.98%
Average
0.00%

Royal Sense Ltd Quarterly Performance

Latest quarterly metrics for ROYAL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

97.46%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

70.59%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Royal Sense Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ROYAL — calculated from daily price history

32RSI 14
Neutral — RSI 32

Momentum is balanced — neither overbought nor oversold.

SMA 50
154
▼ Price below SMA 50 — Short-term bearish
SMA 200
205
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
9K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Royal Sense Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Royal Sense Ltd (ROYAL) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Royal Sense Ltd

About ROYAL (Royal Sense Ltd)

Royal Sense Ltd is a premier provider of specialized medical equipment and comprehensive healthcare solutions, dedicated to enhancing patient care and optimizing medical practices.... With a commitment to excellence and innovation, ROYAL delivers a meticulously curated portfolio of cutting-edge technologies and essential supplies. From advanced diagnostic tools to precision surgical instruments, every product is selected for its superior quality, reliability, and clinical efficacy. ROYAL is driven by a passion for empowering healthcare professionals with the resources they need to deliver exceptional outcomes and improve the lives of those they serve. At the core of Royal Sense Ltd lies an unwavering dedication to meeting the diverse needs of the medical community. The company's expansive range encompasses a broad spectrum of medical equipment, supplies, and specialized solutions. It offers products from medical imaging equipment to sterilization systems. It also offers a range of critical care supplies for hospitals, diagnostic instruments for clinics, and laboratory reagents for research institutions. ROYAL sources products from trusted manufacturers worldwide, adhering to the highest industry standards and regulatory requirements. Royal Sense Ltd is dedicated to building lasting partnerships with hospitals, clinics, laboratories, and healthcare providers. Understanding that each facility has unique requirements, ROYAL offers personalized support and tailored solutions to optimize equipment utilization and improve operational efficiency. With a steadfast commitment to customer satisfaction and a passion for advancing healthcare, ROYAL is a trusted partner in promoting medical excellence and ensuring that every patient receives the highest level of care. Founded on a foundation of integrity and innovation, Royal Sense Ltd is poised to shape the future of medical equipment and supplies, setting new benchmarks for quality, service, and value.

Company Details

Symbol:ROYAL
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies

Key Leadership

Mr. Rishabh Arora
Chairman, MD & CFO
Ms. Ragini Maurya
Company Secretary & Compliance Officer
Mr. Harmeet Singh
Whole Time Director

ROYAL Share Price: Frequently Asked Questions

What is the current share price of Royal Sense Ltd?

Royal Sense Ltd (ROYAL) trades at ₹116.00 on NSE and BSE. Market cap ₹109.14 (Cr). Educational data only.

What is the P/E ratio of Royal Sense Ltd?

Royal Sense Ltd has a P/E of 13.61x vs industry average 47.87x.

What is the Bull Run score for Royal Sense Ltd?

Royal Sense Ltd has a Bull Run score of 52.1/100 based on 25+ financial parameters.

Does Royal Sense Ltd pay dividends?

Royal Sense Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Royal Sense Ltd?

Royal Sense Ltd has ROE of 27.55%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Royal Sense Ltd?

Royal Sense Ltd has debt-to-equity of 0.19.

Is Royal Sense Ltd a good investment?

Bull Run gives Royal Sense Ltd a score of 52.1/100. This is not investment advice — consult a SEBI-registered advisor.